Cardiac toxicity in a phase II study of doxorubicin (DOX) and bevacizumab (BEV) for patients (pts) with metastatic soft-tissue sarcomas (STS)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 9012-9012
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 9012-9012
1994 ◽
Vol 5
(6)
◽
pp. 539-542
◽
1994 ◽
Vol 30
(6)
◽
pp. 842-843
◽
2006 ◽
Vol 59
(2)
◽
pp. 251-259
◽
2011 ◽
Vol 129
(8)
◽
pp. 1963-1969
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 10023-10023
2011 ◽
Vol 81
(4)
◽
pp. 1081-1090
◽